港股异动 | 康诺亚-B(02162)涨近3% 自研BCMA×CD3双抗CM336获FDA授予FTD认定

27 1 月, 2026

One Min Read

14 Views

Last Update: 27 1 月, 2026

Written By

Other Articles

Previous

港股异动 | 基石药业-B(02616)涨超4% 执行董事杨建新再度增持累计买入近1248万股

Next

港股异动 | 君实生物(01877)再涨超5% 成功发行10亿元科技创新债券助力公司研发创新

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept